DATA-CAN partner organisations NHS Lothian and the University of Edinburgh have developed DataLoch, a new secure and pioneering data service which will enable improvements in health and social care in Scotland and across the UK. data-can.org.uk/news-item/data…

Exciting to see scientists from the Glasgow Beatson Institute joining fellow Cancer Research UK colleagues in Edinburgh as part of the new CRUK Scotland Centre - looking forward to new inspiring collaborations Owen Sansom 🏳️‍🌈 @CRUK_BI University of Glasgow The University of Edinburgh Institute of Genetics and Cancer

Look out for us at Scottish Health Economics! Peter Hall Elizabeth Lemmon @bullen_ali & our fresh faced new starter Marek Atter are all attending in person!

Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009–2016: a cross-sectional study link.springer.com/article/10.100…

The protocol for our Health Data Research UK (HDR UK) project "Studying the Long term Impact of COVID in Kids" (SLICK) is now out in BMJ_Open Brilliant team looking at healthcare use in the year after SARS-CoV-2 infection in children across the UK bmjopen.bmj.com/content/12/11/…

🌟Day 01 - Summarising factors with finalfit🌟 #HealthyR #rstats: excerpts from our "R for Health Data Science" book! Comment: when did you last use summary_factorlist()? Any questions: Prof Ewen Harrison and myself happy to answer here! Book chapter here: argoshare.is.ed.ac.uk/healthyr_book/…

“The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment” - work by Edinburgh Cancer Research Institute of Genetics and Cancer @CancerDataEdin investigators and colleagues published in The Oncologist 👇. doi.org/10.1093/oncolo…

Great to see this out. First data from the SCCAMP study - we looked at COVID infection and vaccination status of patients with solid organ cancers undergoing active cancer treatment from the beginning of the pandemic, with longitudinal antibody serology doi.org/10.1093/oncolo…

Check it out! 👆👆👆Real world ongoing study that we are excited to build upon. Truly collaborative, supported by Edinburgh Cancer Research NHS Lothian and an ECAT (Edinburgh Clinical Academic Track) collab in there too. Peter Hall

If interested in #PancreaticCancer, #AI and #DataScience, please apply to join our team PrecisionPanc UofG Cancer Sciences Cancer Research UK in Scotland Edinburgh Cancer Research Peter Hall 👇 findaphd.com/phds/project/f…

Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre mdpi.com/2157404 #mdpicancers via Cancers MDPI

Excellent EBCSS 2023 meeting yesterday. Most well organised meeting with the best programme. Heartiest congratulations to the organising committee.

Having a break from Twitter

RCT of the effect of the omega-3 polyunsaturated fatty acid EPA on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol bmjopen.bmj.com/content/13/11/…

Find me on bsky.app/profile/peterh…

#SABCS24 FDA session highlighting need to consider Minimum Effictive Dose, not just Maximum Tolerated Dose. Reminds me of the GO2 trial last decade. Breast cancer drug development catching up? jamanetwork.com/journals/jamao…

Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial - The Lancet thelancet.com/journals/lance…

Edinburgh Breast Cancer Specialist Symposium 2025 (EBCSS) 21-22 Feb was a great success. Excellent scientific programme, eminent speakers, brilliant talks and superb organisation. Hope to see you all again in Feb 2027